Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-22 4:06 pm Purchase |
2024-02-20 | 13D | Freeline Therapeutics Holdings plc FRLN |
Syncona Portfolio Ltd | 65,872,764 100.000% |
28,010,632 (+73.98%) |
Filing History |
| 2024-02-14 12:15 pm Unchanged |
2023-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN |
Eventide Asset Management, LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-12 4:24 pm Sale |
2023-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN |
Integrated Core Strategies (US) LLC | 0 0.000% |
-5,555,085 (Position Closed) |
Filing History |
| 2024-01-31 4:10 pm Purchase |
2023-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN |
Tetragon Financial Management LP | 6,375,000 9.800% |
6,375,000 (New Position) |
Filing History |
| 2023-11-24 07:30 am Unchanged |
2023-11-22 | 13D | Freeline Therapeutics Holdings plc FRLN |
Syncona Portfolio Ltd | 37,862,132 57.900% |
0 (Unchanged) |
Filing History |
| 2023-10-18 06:04 am Purchase |
2023-10-17 | 13D | Freeline Therapeutics Holdings plc FRLN |
Syncona Portfolio Ltd | 37,862,132 57.920% |
37,862,132 (New Position) |
Filing History |
| 2023-07-17 4:50 pm Purchase |
2023-07-12 | 13G | Freeline Therapeutics Holdings plc FRLN |
Integrated Core Strategies (US) LLC | 5,555,085 8.500% |
5,555,085 (New Position) |
Filing History |
| 2023-02-14 1:54 pm Purchase |
2022-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN |
Eventide Asset Management, LLC | 394,718 9.100% |
162,341 (+69.86%) |
Filing History |
| 2023-02-13 12:01 pm Purchase |
2022-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN |
CHI Advisors LLC | 320,961 7.410% |
195,869 (+156.58%) |
Filing History |
| 2023-01-31 4:15 pm Purchase |
2022-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN |
Tetragon Financial Management LP | 266,667 6.200% |
20,000 (+8.11%) |
Filing History |
| 2022-03-25 4:07 pm Purchase |
2022-03-15 | 13D | Freeline Therapeutics Holdings plc FRLN |
Syncona Portfolio Ltd | 2,524,143 62.270% |
1,269,841 (+101.24%) |
Filing History |
| 2022-03-21 11:10 am Purchase |
2022-03-10 | 13G | Freeline Therapeutics Holdings plc FRLN |
Tetragon Financial Management LP | 246,667 6.100% |
246,667 (New Position) |
Filing History |
| 2022-02-14 11:47 am Purchase |
2021-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN |
Eventide Asset Management, LLC | 232,377 9.700% |
66,667 (+40.23%) |
Filing History |
| 2022-02-11 1:00 pm Purchase |
2021-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN |
CHI Advisors LLC | 125,093 5.240% |
125,093 (New Position) |
Filing History |
| 2022-02-11 12:20 pm Unchanged |
2021-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN |
Syncona Portfolio Ltd | 1,254,302 52.500% |
0 (Unchanged) |
Filing History |
| 2022-02-04 09:06 am Sale |
2021-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN |
WELLINGTON MANAGEMENT CO LLP | 29,320 1.230% |
-91,613 (-75.76%) |
Filing History |
| 2021-11-02 4:32 pm Sale |
2021-11-01 | 13G | Freeline Therapeutics Holdings plc FRLN |
Novo Holdings A/S | 119,038 4.990% |
-38,378 (-24.38%) |
Filing History |
| 2021-08-10 07:57 am Sale |
2021-07-30 | 13G | Freeline Therapeutics Holdings plc FRLN |
WELLINGTON MANAGEMENT CO LLP | 120,932 5.060% |
-113,840 (-48.49%) |
Filing History |
| 2021-02-12 4:07 pm Purchase |
2020-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN |
Eventide Asset Management, LLC | 165,710 7.500% |
165,710 (New Position) |
Filing History |
| 2021-02-12 11:04 am Purchase |
2020-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN |
Syncona Portfolio Ltd | 1,254,302 54.200% |
1,254,302 (New Position) |
Filing History |